Mon, Apr 21, 2014, 6:20 AM EDT - U.S. Markets open in 3 hrs 10 mins


% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • dragan7777777777 dragan7777777777 Nov 8, 2012 4:39 PM Flag

    TKM v. ALNY, date court clock is ticking....

    Pay now, or else later

    "Alnylam Says Estimates of Damages in Tekmira Suit Could Reach $1.5B"

    November 08, 2012

    "Alnylam Pharmaceuticals this week disclosed that a jury trial for its trade secret litigation with Tekmira Pharmaceuticals is expected to begin Nov. 14."

    "These theories estimate Tekmira's damages could be in range of approximately $61 million to $234 million. If aggregated, the “theories of monetary recovery included in [Tekmira's] most recent expert report … would result in damages within a range of approximately $310 million to $484 million,” Alnylam said in the SEC filing".

    “In addition, under one of the plaintiffs’ claims, any compensatory damage award sum could be subject to doubling or trebling, which could increase the potential damages up to approximately $1.5 billion, and the plaintiffs would also be entitled to recover their reasonable attorneys’ fees,” which were reported to be $12.5 million as of June 30 and are likely to now be “significantly higher.”

    SortNewest  |  Oldest  |  Most Replied Expand all replies
53.86-0.75(-1.37%)Apr 17 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
AstraZeneca PLC
NYSEThu, Apr 17, 2014 4:00 PM EDT
NYSEThu, Apr 17, 2014 4:01 PM EDT